^
Association details:
Biomarker:No biomarker
Cancer:Hodgkin Lymphoma
Regimen:AEPA-CAPDAC
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
01/12/2023
Excerpt:
Pediatric Hodgkin Lymphoma….PRIMARY TREATMENT...Other Recommended Regimen...AEPA x 2 cycles (HLHR13)...CAPDAC x 4 cycles.